TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vaccindirekt i Sverige AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
479,175
|
414,643
|
329,180 |
| Financial expenses |
293
|
126
|
138 |
| Earnings before taxes |
62,171
|
80,453
|
70,415 |
| EBITDA |
60,846
|
82,907
|
73,825 |
| Total assets |
173,719
|
174,119
|
106,316 |
| Current assets |
54,736
|
66,296
|
85,714 |
| Current liabilities |
58,493
|
59,021
|
43,579 |
| Equity capital |
106,192
|
106,000
|
58,339 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
181
|
188
|
163 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
61.1%
|
60.9%
|
54.9% |
| Turnover per employee |
2,647
|
2,206
|
2,020 |
| Profit as a percentage of turnover |
13.0%
|
19.4%
|
21.4% |
| Return on assets (ROA) |
36.0%
|
46.3%
|
66.4% |
| Current ratio |
93.6%
|
112.3%
|
196.7% |
| Return on equity (ROE) |
58.5%
|
75.9%
|
120.7% |
| Change turnover |
64,532
|
85,463
|
87,253 |
| Change turnover % |
16%
|
26%
|
36% |
| Chg. No. of employees |
-7
|
25
|
-3 |
| Chg. No. of employees % |
-4%
|
15%
|
-2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.